Opinion
Video
Ronald D. Alvarez, MD, MBA, gives an analysis of the MIRASOL and DESTINY-PanTumor02 trials, including a comparison of study arms and discussion of HER2/neu targeting.
AChR-Ab Titers Associated With Myasthenia Gravis Severity
Five Years Later: Ongoing COVID-19 Challenges, Next Steps
Abortion in 2025: Access, Fertility, and Infant Mortality Updates
Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi
What Recent Evidence Is Telling Us About Alcohol and Cancer
Ovarian Cancer Outcomes Linked to Preoperative Immunonutritional Status